---
type: "Bill"
title: "Ibogaine clinical trials; Oklahoma Breakthrough Therapy Act; terms; requirements for drug developers; contractual terms; intellectual property rights; reports; intellectual property account; effective date."
description: "Ibogaine clinical trials; Oklahoma Breakthrough Therapy Act; terms; requirements for drug developers; contractual terms; intellectual property rights; reports; intellectual property account; effective date."
jurisdiction: "us/states/ok"
legislature: "Oklahoma Legislature"
session: "2026"
identifier: "HB 3834"
citation: "Oklahoma HB 3834 (2026)"
classification: ["bill"]
subjects: []
status: "enacted"
primary_sponsors: ["Frix", "May"]
version_count: 9
action_count: 31
vote_count: 7
first_action: "2026-02-02"
last_action: "2026-05-12"
source: "openstates"
source_identifier: "ocd-bill/3e4d7cb5-2540-4407-9fe8-8d4bfe612713"
source_url: "http://www.oklegislature.gov/BillInfo.aspx?Bill=HB3834&session=2600"
source_hash: "1f64f0c6d35af7b41ee8689c0f36a887a959d2fc5bd7666d8015c271fb2985cb"
vintage: "2026-07-01"
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
retrieved_at: "2026-07-06"
confidence: "reported"
tags: ["legislation", "bill", "us-ok"]
---

# Oklahoma HB 3834 (2026) — Ibogaine clinical trials; Oklahoma Breakthrough Therapy Act; terms; requirements for drug developers; contractual terms; intellectual property rights; reports; intellectual property account; effective date.

## Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. **Introduced** (filed) — [source](https://www.oklegislature.gov/cf_pdf/2025-26 INT/hB/HB3834 INT.PDF)
2. **1 Floor Amendment by MAY (UNTIMELY FILED)** (committee substitute) — [source](https://www.oklegislature.gov/cf_pdf/2025-26 FLOOR AMENDMENTS/House/HB3834 FA1 MAYST-TJ(UNTIMELY FILED).PDF)
3. **Amended And Engrossed** (committee substitute) — [source](https://www.oklegislature.gov/cf_pdf/2025-26 AMENDMENTS/Amendment and Engr/HB3834 SAHB AND ENGR.PDF)
4. **Committee Amendment** (committee substitute) — [source](https://www.oklegislature.gov/cf_pdf/2025-26 COMMITTEE AMENDMENTS/Senate/HB3834 PCS.PDF)
5. **Engrossed** (committee substitute) — [source](https://www.oklegislature.gov/cf_pdf/2025-26 ENGR/hB/HB3834 ENGR.PDF)
6. **Enrolled (final version)** (committee substitute) — [source](https://www.oklegislature.gov/cf_pdf/2025-26 ENR/hB/HB3834 ENR.PDF)
7. **Floor (House)** (committee substitute) — [source](https://www.oklegislature.gov/cf_pdf/2025-26 FLR/HFLR/HB3834 HFLR.PDF)
8. **Floor (Senate)** (committee substitute) — [source](https://www.oklegislature.gov/cf_pdf/2025-26 FLR/SFLR/HB3834 SFLR.PDF)
9. **Senate Committee Substitute for House Bill** (committee substitute) — [source](https://www.oklegislature.gov/cf_pdf/2025-26 COMMITTEE SUBS/SCSH/HB3834 SCSH.PDF)

## Votes

- Fourth Reading — **69–21** (pass) · lower
- Third Reading — **68–23** (pass) · lower
- Public Health Committee: Do Pass — **5–0** (pass) · lower
- Health & Human Services — **10–2** (pass) · upper
- Third Reading — **33–9** (pass) · upper
- Health And Human Services Oversight Committee: Do Pass — **10–0** (pass) · lower
- Appropriations — **20–0** (pass) · upper

## Sponsors

- Frix — primary (person)
- May — primary (person)

## Timeline

The legislative action history — every referral, reading, and vote.

- **2026-02-02** First Reading `introduction, reading-1`
- **2026-02-02** Authored by Representative May
- **2026-02-03** Second Reading referred to Health and Human Services Oversight `reading-2, referral-committee`
- **2026-02-03** Referred to Public Health `referral-committee`
- **2026-02-11** Policy recommendation to the Health and Human Services Oversight committee; Do Pass Public Health `committee-passage`
- **2026-02-11** Coauthored by Representative(s) Pae
- **2026-02-11** Authored by Senator Frix (principal Senate author)
- **2026-02-19** CR; Do Pass Health and Human Services Oversight Committee `committee-passage`
- **2026-03-11** General Order
- **2026-03-11** Amended `amendment-passage`
- **2026-03-11** Third Reading, Measure passed: Ayes: 68 Nays: 23 `passage, reading-3`
- **2026-03-11** Referred for engrossment
- **2026-03-12** Engrossed, signed, to Senate `passage`
- **2026-03-12** First Reading `introduction, reading-1`
- **2026-04-01** Second Reading referred to Health and Human Services Committee then to Appropriations Committee `reading-2, referral-committee`
- **2026-04-13** Reported Do Pass Health and Human Services committee; CR filed `committee-passage`
- **2026-04-13** Referred to Appropriations `referral-committee`
- **2026-04-22** Reported Do Pass, amended by committee substitute Appropriations committee; CR filed `committee-passage`
- **2026-04-27** Placed on General Order
- **2026-04-29** General Order, Considered
- **2026-04-29** Measure passed: Ayes: 33 Nays: 9 `passage`
- **2026-04-29** Referred for engrossment
- **2026-04-30** Engrossed to House `passage`
- **2026-04-30** SA's received
- **2026-05-06** SA's read, adopted
- **2026-05-06** Fourth Reading, Measure passed: Ayes: 69 Nays: 21 `passage`
- **2026-05-06** Referred for enrollment
- **2026-05-06** Enrolled, signed, to Senate
- **2026-05-06** Enrolled measure signed, returned to House
- **2026-05-06** Sent to Governor `executive-receipt`
- **2026-05-12** Approved by Governor 05/12/2026 `executive-signature`

## Source

OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/3e4d7cb5-2540-4407-9fe8-8d4bfe612713`. Confidence: reported (aggregated from official Oklahoma legislature records).